436 related articles for article (PubMed ID: 30458338)
41. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
42. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
43. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
44. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation.
Wada H; Sase T; Matsumoto T; Kushiya F; Sakakura M; Mori Y; Nishikawa M; Ohnishi K; Nakatani K; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2003 Jul; 9(3):233-40. PubMed ID: 14507112
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
46. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome.
Li S; Qian Y; Pei Y; Wu K; Lu S
Front Med (Lausanne); 2021; 8():720342. PubMed ID: 34513881
[No Abstract] [Full Text] [Related]
47. Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs.
Rimpo K; Tanaka A; Ukai M; Ishikawa Y; Hirabayashi M; Shoyama T
PLoS One; 2018; 13(10):e0205511. PubMed ID: 30304025
[TBL] [Abstract][Full Text] [Related]
48. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
49. A prospective analysis of disseminated intravascular coagulation in patients with infections.
Seki Y; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Hatada T; Matsumoto T; Imai H;
Intern Med; 2013; 52(17):1893-8. PubMed ID: 23994978
[TBL] [Abstract][Full Text] [Related]
50. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
51. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
52. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Suga Y; Miyamoto KI; Nakao S
Blood Coagul Fibrinolysis; 2001 Jun; 12(4):275-81. PubMed ID: 11460011
[TBL] [Abstract][Full Text] [Related]
53. [Thrombin.antithrombin III complex].
Matsuo T; Kario K; Matsuo M
Rinsho Byori; 1991 Jul; 39(7):701-6. PubMed ID: 1920862
[TBL] [Abstract][Full Text] [Related]
54. A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation.
Luo L; Wu Y; Niu T; Han Y; Feng Y; Ding Q; Huang R; Zhang X; Feng J; Hou M; Peng J; Li Y; Zhou Y; Su L; Yang L; Zhou Z; Xue F; Gu J; Zhu T; Wang X; Deng J; Mei H; Hu Y
Thromb Res; 2019 Jan; 173():131-140. PubMed ID: 30529391
[TBL] [Abstract][Full Text] [Related]
55. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
Matsuno K; Araki K
Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
[TBL] [Abstract][Full Text] [Related]
56. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
57. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
[TBL] [Abstract][Full Text] [Related]
58. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
59. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
60. [Application Value of Novel Coagulation Markers in Predicting Postoperarative Complications in the Early Stage After Liver Transplantation].
Zhang X; Chen S; Guo J; Zhang Z; Hu H; Yang J; Kang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):1024-1029. PubMed ID: 37866963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
